Visen Pharmaceuticals Expands Supply Agreement with Ascendis Group for Broader Product Access
I'm PortAI, I can summarize articles.
Visen Pharmaceuticals has expanded its supply agreement with Ascendis Group, allowing for the purchase of drug packages, auto-injectors, and ancillary products. This amendment, signed on August 29, 2025, aims to enhance flexibility and resource allocation within the Ascendis Group. CEO Mr. LU An-Bang noted that aside from the disclosed changes, all other details of the agreement remain unchanged. This follows a previous circular regarding connected transactions under the original framework.
Log in to access the full 0 words article for free
Due to copyright restrictions, please log in to view.
Thank you for supporting legitimate content.
Source: Reuters The copyright of this article belongs to the original author/organization.
The views expressed herein are solely those of the author and do not reflect the stance of the platform. The content is intended for investment reference purposes only and shall not be considered as investment advice. Please contact us if you have any questions or suggestions regarding the content services provided by the platform.
Post your comment
No Comments